Axial Spondylarthritis (axSpA) research hub

Treatment Effectiveness in People With axSpA or PsA Starting Treatment With Bimekizumab, Risankizumab, Guselkumab, Upadacitinib, or a TNF Inhibitor

This study looks at how well certain new treatments work for people with types of arthritis called axial spondyloarthritis (axSpA) or psoriatic arthritis (PsA). It gathers information from medical records and patient surveys to understand treatment effectiveness from different viewpoints.